The 'new' alternatives: Private equity, pharmaceutical royalties and reinsurance

clock • 2 min read

PARTNERED INSIGHT: As yields have compressed and forward-looking return expectations fall, multi-asset managers have sought alternatives to traditional asset classes to find new sources of income and boost returns

Driven by the search for income in a prolonged low return environment, the growth of alternatives has continued at a faster pace over the past two decades. Demand for these assets is expected to rise to a staggering US$ 13.6tn by 2020* as investors hunt for uncorrelated sources of return outside of equity and bond sectors.

"The opportunity set within the alternatives sector is truly global and spans a diverse range of often quite specialised sectors. Today this includes private equity, infrastructure, hedge funds, private credit, insurance-linked securities and pharmaceutical royalties to name a few. Yet it wasn't that long ago that these types of alternative investments were the exclusive domain of institutional or specialist investors only," notes Michael Howard, Head of Alternative Investments at Prudential Portfolio Management Group (PPMG). "Newer alternative assets are often idiosyncratic in nature and uncorrelated with both traditional asset classes. Therefore, it is no surprise that they are being accessed much more widely than before."

Alternative substitute

Private equity is one area Howard and his team has invested in significantly over the past decade. The growth of this asset class has been driven by a number of factors. He explains: "More than 6,000 companies were listed in the US in 2000; today that figure is less than 4,000. The reason for that shrinking figure is that IPOs have dried up and when companies are choosing to list they are coming to the market with a much larger capitalisation than average." Effectively the growth period and when higher returns are on offer is all happening at a much earlier stage and predominantly via private capital.

"You can see that quite clearly when you compare the investment return multiples since IPO for Amazon versus Google and Facebook; the latter two were much lower as the growth phase had been enjoyed by private equity groups."

While alternative assets are useful in providing sources of uncorrelated portfolio returns, in other cases, like private equity for example, returns may have a higher correlation to public markets.

Though private equity investments will be investing in different companies with varied outlooks, they are essentially affected by the same thing as publicly listed companies: the economic cycle. Of course, what you do get by investing in private equity is an enhanced return and that is a good reason to consider it over other equity investments in a multi-asset portfolio. Crucially, these enhanced returns are delivered net of fees.

Click here  to read the full article in an exclusive Multi-Asset magazine which reveals how pharmaceutical royalists and insurance-linked securities are taking over from traditional alternatives such as property as investors seek higher returns.

Advertisement

More on Partner Insight

Partner Insight: Advisers - want to feel closer to your clients?

Partner Insight: Advisers - want to feel closer to your clients?

Advising on philanthropy can help to build relationships

Gareth Jones
clock 08 February 2024 • 1 min read
Partner Insight: How philanthropy advice could head off a client crisis

Partner Insight: How philanthropy advice could head off a client crisis

Younger clients are more likely to want advice on charitable giving

Gareth Jones
clock 06 February 2024 • 1 min read
Partner Insight: Will lower quality credit keep performing?

Partner Insight: Will lower quality credit keep performing?

Investors will need to be more selective than ever

Gareth Jones
clock 12 January 2024 • 1 min read
Trustpilot